MyAverix Finance
US · Healthcare
Decision Diagnostics (DECN)
Pharmaceutical Retailers
Decision Diagnostics (DECN) is listed on US in the Healthcare sector. Industry: Pharmaceutical Retailers. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for DECN
Decision Diagnostics (DECN) — FAQ
What is DECN's P/E ratio?
The price-to-earnings (P/E) ratio for Decision Diagnostics (DECN) is 18.00 (data as of 2026-03-24).
Does Decision Diagnostics pay a dividend?
Dividend yield is not available in the current snapshot for Decision Diagnostics (DECN). Check the MyAverix Finance app for the latest dividend data.
What sector is Decision Diagnostics in?
Decision Diagnostics (DECN) is classified in the Healthcare sector (Pharmaceutical Retailers industry).
What exchange is DECN listed on?
DECN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.